Look here for a clue. There's no foolproof way to know the future for Syneron Medical (Nasdaq: ELOS) or any other company. However, certain clues may help you see potential stumbles before they happen ...

Syneron Medical (Nasdaq: ELOS) reported earnings on Feb. 9. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Dec. 31 (Q4), Syneron Medical missed estimates on ...

Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company Combination of Syneron and Candela creates the most comprehensive aesthetic device product ...

IRVINE, Calif. and LONDON, April 3, 2017 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, and Apax Partners, a leading global private equity ...

YOKNEAM, ISRAEL -- (MARKET WIRE) -- 11/10/2008 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos TM combined-energy medical aesthetic devices, today ...

Syneron Medical (NAS: ELOS) is expected to report Q4 earnings on Feb. 12. Here's what Wall Street wants to see: Comparing the upcoming quarter to the prior-year quarter, average analyst estimates ...

BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader ...

WATERTOWN, MA and ZIJTAART, THE NETHERLANDS--(Marketwired - May 30, 2014) - Exergen Global, the worldwide value added supplier and solutions provider of Exergen's corporate line of infrared, ...

BEIJING, Dec. 18, 2025 /PRNewswire/ -- Syneron Bio, an macrocyclic peptide drug discovery company driven by intelligent high-throughput platform, has successfully completed its Series A and A+ ...

IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS) today announced the expiration of the 37-day "go-shop" period under the terms of the previously announced merger ...

Apax Partners LLC has agreed to buy Syneron Medical Ltd. for $397 million in cash. Syneron Medical—also known as Syneron Candela—is based in Israel and maintains a U.S. headquarters in Irvine under ...

Specifically, statements concerning Syneron's financial expectations regarding financial results for the 2005 fiscal year and the first quarter of 2005, as well as statements concerning new product ...